Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Hematologic Neoplasms 1Endometrial Neoplasms 1

Interventions

venetoclax 1ruxolitinib 1isatuximab 1daratumumab 1Tissue Plasminogen Activator 1Therapeutics 1Stem Cell Transplantation 1Psychiatric Rehabilitation 1Oxymorphone 1Oxycodone 1Morphine 1Lisaftoclax 1Levorphanol 1Kidney Transplantation 1Hyperthermia, Induced 1Hydromorphone 1Hydrocodone 1Diathermy 1Counseling 1Cell- and Tissue-Based Therapy 1CF regimen 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Hematologic Neoplasms × Morphine × Clear all
NCT03579446 2025-08-03

Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
43 enrolled
Other hematologic neoplasm

Neoplasm Metastasis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡